-
Choosing February as American Heart Month is not coincidental. With Valentine's Day in February, it is a month in which people are heart-centric, in the spirit of honoring the emotional needs of the heart.
-
Blue Cross Blue Shield of Rhode Island's case management department consistently scores in the 90th percentile on satisfaction surveys sent to members who have completed a case management program.
-
A Medicare demonstration project at Montefiore Medical Center in New York City provides care coordination to help high-cost, fee-for-service beneficiaries comply with their medical treatment plan and access the community services they need to manage their chronic conditions.
-
When it comes to being an effective, professional and ethical case manager, it all boils down to being a good advocate for your clients, John Banja, PhD, asserts.
-
Ariad Pharmaceuticals reported that it has entered a nonexclusive license agreement with Icon Medical to develop drug-eluting stents that deliver Ariad's mTOR inhibitor, deforolimus, to prevent restenosis of injured vessels following angioplasty /stenting.
-
-
-
-
FDA warnings for existing drugs dominate pharmaceutical news this month.
-
Two recent reports provide information regarding durability of complete remission for those treated for acute myeloid leukemia. The rapidity with which blasts are cleared from the peripheral blood turns out to be an excellent predictor of relapse free survival. For those who remain in complete remission at 3 years, cytogenetic features and patient age remain predictors of relapse.